Pathophysiology: Post-Infectious Triggers - Intestinal Parasites

1 Wensaas et al. 2012 — Giardia Bergen Outbreak: 3-Year Follow-Up

Full Citation:: Wensaas K-A, Langeland N, Hanevik K, Mørch K, Eide GE, Rortveit G. Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study. Gut. 2012;61(2):214–219. DOI:: 10.1136/gutjnl-2011-300220 PMID:: 21926063 Published:: 2012 Study Design:: Historic cohort study; 1,252 laboratory-confirmed Giardia cases from the 2004 Bergen waterborne outbreak vs unexposed controls Key Findings::

- 41.5% of chronic fatigue subgroup met CFS criteria at 3 years; combined idiopathic chronic fatigue + CFS prevalence 54.7%
- IBS prevalence 46.1% in Giardia-exposed vs 14% in controls
- Fatigue and bowel symptoms persisted well beyond parasite eradication, confirming post-infectious mechanism

Relevance:: Foundational natural experiment establishing Giardia as a post-infectious ME/CFS trigger. The uniform, documented exposure date provides unusually clean causal inference. Part of the Bergen cohort series — the most rigorous parasitic ME/CFS evidence base in existence. Certainty:: High for association; moderate for causal interpretation (no randomized exposure).

2 Wensaas et al. 2018 — Giardia Bergen Outbreak: 10-Year Follow-Up

Full Citation:: Wensaas K-A, Hanevik K, Hausken T, Eide GE, Langeland N, Rortveit G. Persisting symptoms and duodenal changes in Giardia infection: a 10-year follow-up cohort study. BMC Infectious Diseases. 2018;18(1):46. DOI:: 10.1186/s12879-018-2956-4 PMID:: 29378314 Published:: 2018 Study Design:: 10-year follow-up of the Bergen Giardia outbreak cohort Key Findings::

- 26% of exposed individuals had chronic fatigue at 10 years vs 11% of unexposed controls (RR ~2.4)
- IBS prevalence 43% vs 14% in controls
- Duodenal mucosal changes (villous atrophy, intraepithelial lymphocytes) persisted in a subset
- Fatigue and bowel dysfunction outlasted any detectable active infection by at least 9–10 years

Relevance:: The 10-year persistence of elevated fatigue prevalence in an exposed-vs-unexposed cohort is among the strongest population-level evidence linking a parasitic infection to chronic fatigue syndrome. Cannot be attributed to ongoing infection or recall bias from acute disease. Certainty:: High for association at population level.

3 Bolstad et al. 2017 — Immune Persistence After Giardia in Post-Infectious CFS

Full Citation:: Bolstad N, Wensaas K-A, Hanevik K, Langeland N, Nkrumah B, Rortveit G, Mørch K. Long-term humoral and cellular immunity after acute giardiasis in Bergen patients with and without post-infectious fatigue. Journal of Infection. 2017;74(3):295–303. DOI:: 10.1016/j.jinf.2016.11.011 PMID:: 27919709 Published:: 2017 Study Design:: Immunological sub-study of the Bergen Giardia cohort; comparison of immune profiles between post-giardiasis CFS patients and non-CFS exposed individuals Key Findings::

- Persistent *Giardia*-specific cellular immune responses (T-cell proliferation and cytokine production) detected in post-giardiasis CFS patients at 5+ years
- Elevated parasite-specific IgG persisted in the CFS subgroup compared to non-CFS exposed
- Immune activation was ongoing in the absence of detectable active parasite

Relevance:: Provides the mechanistic link for the Bergen cohort observations: the sustaining mechanism is ongoing parasite-specific immune activation, not continued parasitic presence. Directly supports the inciting trigger vs sustaining mechanism framework. Analogous to post-viral immune activation documented in EBV- and COVID-triggered ME/CFS. Certainty:: Moderate (small immunological sub-cohort; mechanistic link plausible but not proven causal).

4 Naess et al. 2012 — Post-Giardia CFS: Clinical Characterisation and Disability

Full Citation:: Naess H, Nyland M, Hausken T, Follestad I, Nyland HI. Chronic fatigue syndrome after Giardia enteritis: clinical characteristics, disability and long-term sickness absence. BMC Gastroenterology. 2012;12:13. DOI:: 10.1186/1471-230X-12-13 PMID:: 22316329 PMCID:: PMC3292445 Published:: February 2012 Study Design:: Case series; 58 CFS cases from the Bergen 2004 Giardia outbreak, mean illness duration 2.7 years at specialist referral Key Findings::

- At least 5% of all laboratory-confirmed Giardia cases developed full CFS meeting Fukuda criteria
- Progressive worsening course in 57% at time of referral; 16% improved, 28% stable
- SF-36 profile: disproportionate impairment in physical functioning, vitality, and social functioning; mental health relatively preserved
- All 58 patients had long-term sickness absence from work or study

Relevance:: Provides clinical phenotyping of post-parasitic CFS from a well-defined exposure cohort. The SF-36 profile (physical > mental impairment) aligns with ME/CFS rather than primary depression. Quantifies minimum incidence: 5% of lab-confirmed Giardia cases → clinical ME/CFS. The predominantly progressive (not self-limiting) course at 2.7 years contradicts assumption of spontaneous resolution. Limitations:: Case series design; no matched controls; subset referred to specialist, not population-wide screening. Certainty:: Moderate (well-defined exposure, systematic CFS diagnosis; selection bias possible).

5 Mørch et al. 2013 — Post-Giardia CFS: 5-Year Natural Course and Differential Diagnosis

Full Citation:: Mørch K, Hanevik K, Rivenes AC, Bødtker JE, Næss H, Stubhaug B, Wensaas K-A, Rortveit G, Eide GE, Hausken T, Langeland N. Chronic fatigue syndrome 5 years after giardiasis: differential diagnoses, characteristics and natural course. BMC Gastroenterology. 2013;13:28. DOI:: 10.1186/1471-230X-13-28 PMID:: 23399438 PMCID:: PMC3598369 Published:: February 2013 Study Design:: Prospective follow-up; 53 persistently fatigued post-Giardia patients evaluated by multi-specialist panel (psychiatry, neurology, infectious disease) at 5 years Key Findings::

- 41.5% (22/53) met Fukuda CFS criteria at 5 years; 13.2% had idiopathic chronic fatigue
- Important differential diagnoses identified: sleep apnoea (n=5), depression (n=6), anxiety (n=5)
- 20.8% had resolved by 5 years; fatigue scores improved significantly from 3 to 5 years
- CFS group showed persistent functional impairment despite 5 years since infection

Relevance:: Establishes that post-parasitic CFS can persist for at least 5 years in a substantial minority. Multi-specialist diagnostic rigor demonstrates that persistent post-Giardia fatigue is not simply missed depression or sleep apnoea in most cases — though these remain important differentials to exclude. Provides temporal trajectory: slow partial recovery occurs, but majority remain ill. Limitations:: Only 53/253 eligible patients participated (self-selection bias possible); small subgroup for differential analyses. Certainty:: Moderate (multi-specialist diagnosis is strength; selection bias and small n are limitations).

6 Hanevik et al. 2012 — NK Cell Reduction in Post-Giardia CFS: Immunophenotyping

Full Citation:: Hanevik K, Kristoffersen EK, Sørnes S, Mørch K, Næss H, Rivenes AC, Bødtker JE, Hausken T, Langeland N. Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome. BMC Infectious Diseases. 2012;12:258. DOI:: 10.1186/1471-2334-12-258 PMID:: 23061432 PMCID:: PMC3553045 Published:: October 2012 Study Design:: Immunological cross-sectional sub-study of the Bergen Giardia cohort at 5 years post-infection; compares post-infectious CFS, post-infectious functional GI disease, and non-fatigued exposed controls Key Findings::

- Post-infectious CFS patients had significantly lower NK-cell counts vs non-fatigued Giardia-exposed controls at 5 years
- NK-cell levels correlated negatively with fatigue severity and abdominal symptom severity
- Post-infectious FGID showed higher CD8 T-cell levels (distinct immune profile from CFS subgroup)
- No significant difference in most other immune markers between groups

Relevance:: First objective immunological marker differentiating post-parasitic CFS from recovered Giardia cases. The NK-cell reduction at 5 years mirrors the chronic NK dysfunction documented in ME/CFS from viral triggers (Section Innate Immunity), providing cross-etiology mechanistic convergence. The correlation between NK levels and symptom severity suggests NK dysfunction is not incidental. Supports the hypothesis that post-parasitic ME/CFS shares immunological hallmarks with post-viral ME/CFS regardless of the triggering pathogen. Limitations:: Small n (19 CFS cases); cross-sectional measurement cannot establish causality; single cohort. Certainty:: Moderate (well-defined exposure and consistent NK findings with broader ME/CFS literature).

7 Hanevik et al. 2014 — Post-Giardia CFS: 6-Year Controlled Prospective Cohort

Full Citation:: Hanevik K, Wensaas K-A, Rortveit G, Eide GE, Mørch K, Langeland N. Irritable bowel syndrome and chronic fatigue 6 years after giardia infection: a controlled prospective cohort study. Clinical Infectious Diseases. 2014;59(10):1394–1400. DOI:: 10.1093/cid/ciu629 PMID:: 25115874 PMCID:: PMC4207419 Published:: November 2014 Study Design:: Controlled prospective cohort; 748 Giardia-exposed vs 878 matched population controls; postal questionnaire at 6 years Key Findings::

- Chronic fatigue in 30.8% of exposed vs controls: RR 2.9 (95% CI 2.3–3.4)
- IBS in 39.4% of exposed vs controls: RR 3.4 (95% CI 2.9–3.9)
- From 3 to 6 years: chronic fatigue prevalence fell 15%, IBS fell 7% — slow partial recovery
- Increasing age was a risk factor for persisting chronic fatigue

Relevance:: The methodologically strongest study in the Bergen series — controlled, prospective, large matched cohort. Establishes a nearly threefold excess risk of chronic fatigue six years after documented parasitic infection at population scale. The controlled design allows true excess-risk calculation not confounded by background rates. The temporal trajectory (slow decline from 3-year peak) supports the disease course hypothesis: post-parasitic ME/CFS is not immediately self-limiting but does show partial natural recovery over years. Limitations:: Self-report outcomes (postal questionnaire); formal ME/CFS diagnostic criteria not applied to full cohort; response rate not specified in abstract. Certainty:: High (for post-Giardia excess chronic fatigue risk at population level).

8 Hanevik et al. 2017 — sCD40L Elevation in Post-Giardia CFS: Immune Activation Marker

Full Citation:: Hanevik K, Kristoffersen E, Mørch K, Rye KP, Sørnes S, Svärd S, Bruserud Ø, Langeland N. Giardia-specific cellular immune responses in post-giardiasis chronic fatigue syndrome. BMC Immunology. 2017;18(1):5. DOI:: 10.1186/s12865-017-0190-3 PMID:: 28129747 PMCID:: PMC5279576 Published:: January 2017 Study Design:: Immunological sub-study of Bergen cohort; comparison of antigen-specific T-cell responses and sCD40L levels between PI-CFS, non-fatigued post-Giardia controls, and unexposed healthy controls Key Findings::

- Antigen-specific CD4 T-cell activation and proliferation did not differentiate PI-CFS from non-fatigued Giardia-exposed controls
- Elevated soluble CD40 ligand (sCD40L) in PI-CFS and fatigued post-Giardia patients vs non-fatigued controls
- sCD40L correlated positively with current fatigue severity
- Giardia-specific immune memory (antigen recall response) was detectable in exposed vs unexposed groups

Relevance:: sCD40L is a marker of platelet activation and CD4 T-cell–mediated immune activation. Its elevation in proportion to fatigue severity suggests ongoing systemic immune activation as a fatigue-sustaining mechanism, not merely residual antigen-specific T-cell memory. The negative finding for antigen-specific CD4 T-cell responses (despite positive Bolstad 2017 findings for cellular immunity) may reflect methodological differences or a shift from Giardia-specific to bystander immune activation at this later timepoint. Limitations:: Small n (15 CFS cases); sCD40L finding requires independent replication; cross-sectional design. Certainty:: Moderate (novel finding; awaits replication).

9 Stiff et al. 2017 — Post-Cryptosporidium Persistent Symptoms: 1-Year Follow-Up

Full Citation:: Stiff RE, Davies AP, Mason BW, Hutchings HA, Chalmers RM. Long-term health effects after resolution of acute Cryptosporidium parvum infection: a 1-year follow-up of outbreak-associated cases. Journal of Medical Microbiology. 2017;66(11):1607–1611. DOI:: 10.1099/jmm.0.000609 PMID:: 28984243 Published:: November 2017 Study Design:: Longitudinal follow-up of adult outbreak-associated Cryptosporidium parvum cohort; self-reported symptoms at 12 months post-infection Key Findings::

- Persistent fatigue in 22% at 12 months post-infection
- Joint pain 33%, abdominal pain 38%, diarrhoea 33%, IBS-consistent symptoms 28%
- Multi-system symptom cluster extending beyond GI involvement
- First study to describe 12-month sequelae of C. parvum; sequelae similar to C. hominis

Relevance:: Extends the post-infectious ME/CFS trigger spectrum beyond Giardia to a second waterborne protozoan. The multi-system phenotype (fatigue + joint pain + GI) is consistent with post-infectious ME/CFS. Formal CFS diagnostic criteria were not applied and follow-up was limited to 12 months — insufficient for full ME/CFS ascertainment (most ME/CFS diagnoses require ≥6 months, and the Bergen data show peak CFS prevalence at 3 years). This study should be understood as preliminary evidence requiring longer follow-up and formal diagnostic ascertainment. Limitations:: No control group; 12-month follow-up too short for ME/CFS assessment; CFS criteria not applied; likely small sample; single C. parvum subtype. Certainty:: Low-moderate (consistent with trigger hypothesis; insufficient for definitive conclusion).

10 Jason et al. 2022 — Patient-Reported Infectious Triggers of ME/CFS: 100+ Pathogens

Full Citation:: Jason LA, Yoo S, Bhatia S. Patient perceptions of infectious illnesses preceding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Chronic Illness. 2022;18(4):901–910. DOI:: 10.1177/17423953211043106 PMID:: 34541918 PMCID:: PMC9152619 Published:: 2022 Study Design:: Multi-site, multi-country cross-sectional survey; 1,773 individuals diagnosed with ME, CFS, or ME/CFS; qualitative open-ended reporting of preceding infectious illness Key Findings::

- 60.3% of 1,773 ME/CFS patients reported a preceding infectious illness
- Most common single trigger: mononucleosis/EBV (30% of those with infectious triggers)
- Over 100 distinct infectious agents identified in total
- No single pathogen dominates; trigger spectrum is highly diverse
- Parasitic triggers documented (Giardia, amoeba, tapeworm) but represent a minority

Relevance:: Establishes the empirical basis for the diverse-trigger model of post-infectious ME/CFS onset. The dominance of no single pathogen (EBV, despite being #1, accounts for only 30% of infectious triggers) supports the hypothesis that severity and duration of the host immune response — not the specific pathogen — is the primary determinant of ME/CFS conversion. Contextualises parasite-triggered ME/CFS as a real but minority pathway within a broader post-infectious spectrum. Limitations:: Entirely self-reported and retrospective; recall bias and misattribution risk; no control group; no parasitic triggers quantified separately (grouped under “other”); qualitative coding reliability not detailed. Certainty:: Moderate (large multi-country sample; limited by retrospective self-report design).

11 Dunwell 2013 — ME/CFS and Blastocystis / Dientamoeba: Clinical Comparison

Full Citation:: Dunwell D. ME/CFS and Blastocystis spp or Dientamoeba fragilis, an in-house comparison. The British Journal of General Practice. 2013;63(607):73–74. DOI:: 10.3399/bjgp13X663028 PMID:: 23561675 PMCID:: PMC3553628 Published:: February 2013 Study Design:: Clinical letter; in-house case series comparison Key Findings::

- Documents ME/CFS patients positive for *Blastocystis* spp or *Dientamoeba fragilis* in a UK general practice
- Raises the question of whether these organisms are incidental findings or contributors to symptom burden

Relevance:: Earliest UK primary care documentation of the ME/CFS–Blastocystis/Dientamoeba intersection. Methodologically limited (letter, no control group) but clinically significant as a first flag for a gap in routine investigation. Highlights the diagnostic sensitivity limitation of standard O&P microscopy for these organisms. Limitations:: Letter format; no control group; no PCR confirmation of subtype; cannot establish causation or prevalence. Certainty:: Low (case series letter). Cited as hypothesis-generating, not as evidence of association.